标题
Delivery strategies of RNA therapeutics to leukocytes
作者
关键词
RNA, Drug delivery, Leukocytes, Nanocarriers, mRNA
出版物
JOURNAL OF CONTROLLED RELEASE
Volume 342, Issue -, Pages 362-371
出版商
Elsevier BV
发表日期
2022-01-15
DOI
10.1016/j.jconrel.2022.01.016
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Nanoparticle delivery of microRNA-146a regulates mechanotransduction in lung macrophages and mitigates injury during mechanical ventilation
- (2021) Christopher M. Bobba et al. Nature Communications
- Conformation-sensitive targeting of lipid nanoparticles for RNA therapeutics
- (2021) Niels Dammes et al. Nature Nanotechnology
- Exosome membrane-modified M2 macrophages targeted nanomedicine: Treatment for allergic asthma
- (2021) Weiya Pei et al. JOURNAL OF CONTROLLED RELEASE
- Givosiran: First Approval
- (2020) Lesley J. Scott DRUGS
- Folate receptor-targeted RNAi nanoparticles for silencing STAT3 in tumor-associated macrophages and tumor cells
- (2020) Jing Chen et al. Nanomedicine-Nanotechnology Biology and Medicine
- RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs
- (2020) Sarah Bajan et al. Cells
- Targeted lipid nanoparticles for RNA therapeutics and immunomodulation in leukocytes
- (2020) Nuphar Veiga et al. ADVANCED DRUG DELIVERY REVIEWS
- Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy
- (2020) Zhaoying Fu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Exosome‐based targeted RNA delivery for immune tolerance induction in skin transplantation
- (2020) Chunmin Li et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
- Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing
- (2020) Qiang Cheng et al. Nature Nanotechnology
- The powerful world of antisense oligonucleotides: From bench to bedside
- (2020) Anaïs M. Quemener et al. Wiley Interdisciplinary Reviews-RNA
- siRNA nanoparticles targeting CaMKIIγ in lesional macrophages improve atherosclerotic plaque stability in mice
- (2020) Wei Tao et al. Science Translational Medicine
- Macrophage Sphingosine 1-Phosphate Receptor 2 Blockade Attenuates Liver Inflammation and Fibrogenesis Triggered by NLRP3 Inflammasome
- (2020) Lei Hou et al. Frontiers in Immunology
- M2-Like Tumor-Associated Macrophage-Targeted Codelivery of STAT6 Inhibitor and IKKβ siRNA Induces M2-to-M1 Repolarization for Cancer Immunotherapy with Low Immune Side Effects
- (2020) Hong Xiao et al. ACS Central Science
- Paving the Road for RNA Therapeutics
- (2020) Niels Dammes et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth In Vitro and In Vivo
- (2020) Eleni Anastasiadou et al. CLINICAL CANCER RESEARCH
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo
- (2020) N. N. Parayath et al. Nature Communications
- The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020
- (2020) Sara E. Oliver et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Targeted Delivery of miRNA 155 to Tumor Associated Macrophages for Tumor Immunotherapy
- (2019) Xinlong Zang et al. MOLECULAR PHARMACEUTICS
- Messenger RNA therapy for rare genetic metabolic diseases
- (2019) Pedro Berraondo et al. GUT
- Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo
- (2019) Nidhi Jyotsana et al. ANNALS OF HEMATOLOGY
- ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in a CLL mouse model
- (2019) Chi-Ling Chiang et al. BLOOD
- Constrained Nanoparticles Deliver siRNA and sgRNA to T Cells In Vivo without Targeting Ligands
- (2019) Melissa P. Lokugamage et al. ADVANCED MATERIALS
- Lipid nanoparticle-targeted mRNA therapy as a treatment for the inherited metabolic liver disorder arginase deficiency
- (2019) Brian Truong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Enlisting the mRNA Vaccine Platform to Combat Parasitic Infections
- (2019) Leroy Versteeg et al. Vaccines
- In situ repurposing of dendritic cells with CRISPR/Cas9-based nanomedicine to induce transplant tolerance
- (2019) Yue Zhang et al. BIOMATERIALS
- Leukocyte-specific siRNA delivery revealing IRF8 as a potential anti-inflammatory target
- (2019) Nuphar Veiga et al. JOURNAL OF CONTROLLED RELEASE
- siRNA/lipopolymer nanoparticles to arrest growth of chronic myeloid leukemia cells in vitro and in vivo
- (2018) Juliana Valencia-Serna et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- A modular platform for targeted RNAi therapeutics
- (2018) Ranit Kedmi et al. Nature Nanotechnology
- Glimmers in illuminating the druggable genome
- (2018) Griffin Rodgers et al. NATURE REVIEWS DRUG DISCOVERY
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- The efficiency of lipid nanoparticles with an original cationic lipid as a siRNA delivery system for macrophages and dendritic cells
- (2018) Yasunori Uemura et al. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- Engineering the Delivery System for CRISPR-Based Genome Editing
- (2018) Zachary Glass et al. TRENDS IN BIOTECHNOLOGY
- Progress and challenges towards targeted delivery of cancer therapeutics
- (2018) Daniel Rosenblum et al. Nature Communications
- Receptor-targeted aptamer-siRNA conjugate-directed transcriptional regulation of HIV-1
- (2018) Jiehua Zhou et al. Theranostics
- The great escape: how cationic polyplexes overcome the endosomal barrier
- (2018) Tanja Bus et al. Journal of Materials Chemistry B
- mRNA-Based Protein Replacement Therapy for the Heart
- (2018) Ajit Magadum et al. MOLECULAR THERAPY
- Small-molecule-based regulation of RNA-delivered circuits in mammalian cells
- (2018) Tyler E. Wagner et al. Nature Chemical Biology
- Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes
- (2018) Nuphar Veiga et al. Nature Communications
- Aptamer-Targeted Attenuation of IL-2 Signaling in CD8 + T Cells Enhances Antitumor Immunity
- (2017) Anugraha Rajagopalan et al. MOLECULAR THERAPY
- Current Progress in Non-viral RNAi-Based Delivery Strategies to Lymphocytes
- (2017) Shoshy Mizrahy et al. MOLECULAR THERAPY
- Lipid Nanoparticle Systems for Enabling Gene Therapies
- (2017) Pieter R. Cullis et al. MOLECULAR THERAPY
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model
- (2017) L D’Abundo et al. ONCOGENE
- Delivering the right message: Challenges and opportunities in lipid nanoparticles-mediated modified mRNA therapeutics—An innate immune system standpoint
- (2017) Yasmin Granot et al. SEMINARS IN IMMUNOLOGY
- Role of TLR9 in Oncogenic Virus-Produced Cancer
- (2017) Cecilia Martínez-Campos et al. VIRAL IMMUNOLOGY
- Advances in the delivery of RNA therapeutics: from concept to clinical reality
- (2017) James C. Kaczmarek et al. Genome Medicine
- Targeted delivery of siRNA to activated T cells via transferrin-polyethylenimine (Tf-PEI) as a potential therapy of asthma
- (2016) Yuran Xie et al. JOURNAL OF CONTROLLED RELEASE
- Immunomodulation of hematological malignancies using oligonucleotides based-nanomedicines
- (2016) Inbal Hazan-Halevy et al. JOURNAL OF CONTROLLED RELEASE
- Advances in RNAi therapeutic delivery to leukocytes using lipid nanoparticles
- (2016) Srinivas Ramishetti et al. JOURNAL OF DRUG TARGETING
- Peptide- and Amine-Modified Glucan Particles for the Delivery of Therapeutic siRNA
- (2016) Jessica L. Cohen et al. MOLECULAR PHARMACEUTICS
- Aptamers as targeted therapeutics: current potential and challenges
- (2016) Jiehua Zhou et al. NATURE REVIEWS DRUG DISCOVERY
- Exosome-mediated small RNA delivery for gene therapy
- (2016) Yu Zhou et al. Wiley Interdisciplinary Reviews-RNA
- Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles
- (2015) Srinivas Ramishetti et al. ACS Nano
- Modified mRNA as an alternative to plasmid DNA (pDNA) for transcript replacement and vaccination therapy
- (2015) Hyewon Youn et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Knocking down disease: a progress report on siRNA therapeutics
- (2015) Anders Wittrup et al. NATURE REVIEWS GENETICS
- Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies
- (2015) Shiri Weinstein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma
- (2015) Donato Cosco et al. Scientific Reports
- Development and Applications of CRISPR-Cas9 for Genome Engineering
- (2014) Patrick D. Hsu et al. CELL
- CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells
- (2014) Andreas Herrmann et al. JOURNAL OF CLINICAL INVESTIGATION
- SNS01-T Modulation of eIF5A Inhibits B-cell Cancer Progression and Synergizes With Bortezomib and Lenalidomide
- (2014) Sarah M Francis et al. MOLECULAR THERAPY
- Non-viral vectors for gene-based therapy
- (2014) Hao Yin et al. NATURE REVIEWS GENETICS
- In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma
- (2014) Maria Teresa Di Martino et al. PLoS One
- TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivo
- (2013) Q. Zhang et al. BLOOD
- A daunting task: manipulating leukocyte function with RNAi
- (2013) Dan Peer IMMUNOLOGICAL REVIEWS
- Aptamer-targeted inhibition of mTOR in T cells enhances antitumor immunity
- (2013) Alexey Berezhnoy et al. JOURNAL OF CLINICAL INVESTIGATION
- Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape
- (2013) Jerome Gilleron et al. NATURE BIOTECHNOLOGY
- RNA-Guided Human Genome Engineering via Cas9
- (2013) P. Mali et al. SCIENCE
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo
- (2012) V J Craig et al. LEUKEMIA
- Modulation of eIF5A Expression Using SNS01 Nanoparticles Inhibits NF-κB Activity and Tumor Growth in Murine Models of Multiple Myeloma
- (2012) Catherine A Taylor et al. MOLECULAR THERAPY
- Functional In Vivo Delivery of Multiplexed Anti-HIV-1 siRNAs via a Chemically Synthesized Aptamer With a Sticky Bridge
- (2012) Jiehua Zhou et al. MOLECULAR THERAPY
- Nonviral delivery of self-amplifying RNA vaccines
- (2012) A. J. Geall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma
- (2012) I. A. Babar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Systemic RNAi-mediated Gene Silencing in Nonhuman Primate and Rodent Myeloid Cells
- (2012) Tatiana I Novobrantseva et al. Molecular Therapy-Nucleic Acids
- Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras
- (2011) Lee Adam Wheeler et al. JOURNAL OF CLINICAL INVESTIGATION
- Systemic Administration of Combinatorial dsiRNAs via Nanoparticles Efficiently Suppresses HIV-1 Infection in Humanized Mice
- (2011) Jiehua Zhou et al. MOLECULAR THERAPY
- Therapeutic siRNA silencing in inflammatory monocytes in mice
- (2011) Florian Leuschner et al. NATURE BIOTECHNOLOGY
- An Aptamer-siRNA Chimera Suppresses HIV-1 Viral Loads and Protects from Helper CD4+ T Cell Decline in Humanized Mice
- (2011) C. P. Neff et al. Science Translational Medicine
- Discovery and Development of Therapeutic Aptamers
- (2010) P.R. Bouchard et al. Annual Review of Pharmacology and Toxicology
- Targeting Stat3 in the Myeloid Compartment Drastically Improves the In vivo Antitumor Functions of Adoptively Transferred T Cells
- (2010) A. Herrmann et al. CANCER RESEARCH
- Endosomal escape pathways for delivery of biologicals
- (2010) Amir K. Varkouhi et al. JOURNAL OF CONTROLLED RELEASE
- Targeted Delivery of siRNA to Macrophages for Anti-inflammatory Treatment
- (2010) Sang-Soo Kim et al. MOLECULAR THERAPY
- RNAi-mediated CCR5 Silencing by LFA-1-targeted Nanoparticles Prevents HIV Infection in BLT Mice
- (2009) Sang-Soo Kim et al. MOLECULAR THERAPY
- Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation
- (2009) Myriam Aouadi et al. NATURE
- In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses
- (2009) Marcin Kortylewski et al. NATURE BIOTECHNOLOGY
- Knocking down barriers: advances in siRNA delivery
- (2009) Kathryn A. Whitehead et al. NATURE REVIEWS DRUG DISCOVERY
- TARGETED DELIVERY OF siRNA TO CELL DEATH PROTEINS IN SEPSIS
- (2009) Pavan Brahmamdam et al. SHOCK
- T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized Mice
- (2008) Priti Kumar et al. CELL
- Chemical Modification of siRNAs for In Vivo Use
- (2008) Mark A. Behlke OLIGONUCLEOTIDES
- Toll-like receptor 9 (TLR9) agonists in the treatment of cancer
- (2008) A M Krieg ONCOGENE
- Systemic Leukocyte-Directed siRNA Delivery Revealing Cyclin D1 as an Anti-Inflammatory Target
- (2008) D. Peer et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now